" /> Anti-CD19/CD20/CD22 CAR T-Cells - CISMeF





Preferred Label : Anti-CD19/CD20/CD22 CAR T-Cells;

NCIt synonyms : Anti-CD19/20/22 Chimeric Antigen Receptor T-Cells; CD19/CD20/CD22-targeted CAR-T Cells;

NCIt definition : A preparation of human T-lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigens (TAAs) cluster of differentiation 19 (CD19), CD20 and CD22, with potential immunostimulating and antineoplastic activities. Upon administration, the anti-CD19/CD20/CD22 CAR-T cells target and bind to CD19, CD20 and CD22 expressed on the surface of certain tumor cells. This induces selective toxicity in tumor cells expressing these TAAs. The TAAs are overexpressed in certain hematologic malignancies.;

NCI Metathesaurus CUI : CL1779121;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.